Abstract
Multiple sclerosis is an important chronic disorders of central nervous system that can lead to severe disability because of the presence of multiple demyelinating lesion. We report a 20-year-old woman with relapsing-remitting MS, with pediatric onset of MS, who developed aggressive disease with visual acuity lost (1/60 in both eyes). Frequent magnetic resonance imaging (MRI) detected persisting inflammatory activity and increase of lesion burden so she was submitted to natalizumab treatment with stability of MRI. After about 10 administrations of natalizumab, she improved her visual acuity in left eye (visual acuity 1/10); visual evocate potential show mild improvement of latency in left eye.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
